DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Stocks to Watch for September 15: HDFC Bank, BSE, IT Stocks, Coforge, Tata Chemicals and more

CNBC-TV18 1 hr ago·14 Sept 2026, 5:35 am

Tata Chemicals is in focus as the Tata Group explores the potential listing of its holding company, Tata Sons. This strategic move could unlock significant value for the conglomerate and its listed subsidiaries.

For investors, this development is important because a listing often signals a new phase of growth and transparency. It may also lead to increased liquidity and a potential re-rating of the group's stocks.

Investors should watch for official announcements from the Tata Group regarding the timeline and structure of the proposed listing. The market's reaction to any news will be a key indicator of investor sentiment.